Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
FEBUXOSTAT TABLETS. These highlights do not include all the information needed to use FEBUXOSTAT TABLETS safely and effectively. See full prescribing information for FEBUXOSTAT TABLETS. FEBUXOSTAT tablets, for oral use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
Febuxostat Tablets are a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. Limitations of Use: Febuxostat Tablets are not recommended for the treatment of asymptomatic hyperuricemia.
- generic_name
- febuxostat
- product_names
- Febuxostat
- ndc
- 51407-293, 51407-294, 0054-0413, 51407-293-30, 0054-0414, 51407-294-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en